창상 피복재 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Wound Dressing Market Growth & Trends:

The global wound dressing market size is estimated to reach USD 18.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 4.16% from 2024 to 2030. An increasing number of people suffering from chronic wounds, a rise in technologically advanced dressing, and rising cases of traumatic accidents are expected to be the key driving factors for the market.

The number of people suffering from diabetic foot ulcers is increasing, due to a rise in chronic disorders like diabetes. For instance, as per the International Diabetes Federation (IDF), an estimated population of 61 million people aged between 20-79 years living in Europe were suffering from diabetes. Similarly, according to the National Center for Biotechnology Information (NCBI), the incidence rate of diabetes foot ulcers globally is between 9.1 million to 26.1 million annually. Thus, the rise in diabetes & diabetic foot ulcer patients is increasing the demand for wound dressing products.

Moreover, there has been a global increase in the number of traumatic accidents such as burns, gunshots, and road accidents. For instance, according to statistics by the World Health Organization (WHO) in October 2023, approximately 11 million burn cases occurred worldwide, which led to 180,000 deaths globally. Similarly, as per NCBI, every day, more than 30,000 burn cases are registered globally. Therefore, the rising global number of burn cases is anticipated to impel the market over the forecast period.

Wound Dressing Market Report Highlights:

• Based on product, the advanced dressing segment dominated the market in 2023. This can be attributed to globally rising cases of traumatic accidents
• Based on application, the chronic wounds segment dominated the market in 2023
• Based on end-use, the hospital segment dominated the market in 2023. This can be credited to rising surgical procedures and an increasing number of hospitals
• North America dominated the market in 2023. This dominance can be accredited to well-developed healthcare infrastructure, increasing awareness, and the presence of major key players in the region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Wound Dressing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
    • 3.2.1.2. Introduction of innovative and advanced wound products
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Increasing number of ambulatory surgical centers (ASCs)
    • 3.2.1.5. Increasing number of accidents
    • 3.2.1.6. Steep rise in the number of hospitals & urgent care centers and increase in hospital admissions
    • 3.2.1.7. Improvements in public and private hospital infrastructure
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Delayed diagnosis and lower treatment rates in emerging nations
    • 3.2.2.2. High cost of advanced wound care products and chronic wound treatments
    • 3.2.2.3. Stringent manufacturing policies
• 3.3. Wound dressing market analysis tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Wound Dressing Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Advanced dressings
  • 4.1.2. Traditional dressings
• 4.2. Product Market Share, 2023 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Wound Dressing Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Traditional wound dressing
    • 4.5.1.1. Traditional wound dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.2. Gauze
    • 4.5.1.2.1. Gauze market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.3. Tape
    • 4.5.1.3.1. Tape market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.4. Bandages
    • 4.5.1.4.1. Bandages market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.5. Cotton
    • 4.5.1.5.1. Cotton market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.6. Others
    • 4.5.1.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Advanced dressings
    • 4.5.2.1. Advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2. Moist dressings
    • 4.5.2.2.1. Moist dressings market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.2. Foam dressing
    • 4.5.2.2.2.1. Foam dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.3. Hydrocolloid dressing
    • 4.5.2.2.3.1. Hydrocolloid dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.4. Film dressing
    • 4.5.2.2.4.1. Film dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.5. Alginate dressing
    • 4.5.2.2.5.1. Alginate dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.6. Hydrogel dressing
    • 4.5.2.2.6.1. Hydrogel dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.7. Collagen dressing
    • 4.5.2.2.7.1. Collagen dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.8. Other advanced dressing
    • 4.5.2.2.8.1. Other advanced dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.3. Antimicrobial dressings
    • 4.5.2.3.1. Antimicrobial dressings market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.3.2. Silver
    • 4.5.2.3.2.1. Silver market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.3.3. Non-silver
    • 4.5.2.3.3.1. Non-silver market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.4. Active dressings
    • 4.5.2.4.1. Active dressings market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.4.2. Biomaterials
    • 4.5.2.4.2.1. Biomaterials market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.4.3. Skin-substitutes
    • 4.5.2.4.3.1. Skin-substitutes market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Wound dressing Market: Application Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Chronic wounds
  • 5.1.2. Acute wounds
• 5.2. Application Market Share, 2023 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Wound Dressing Market by Application Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Chronic wounds
    • 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 5.5.1.2. Diabetic foot ulcers
    • 5.5.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.3. Pressure ulcers
    • 5.5.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.4. Venous leg ulcers
    • 5.5.1.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.5. Other chronic wounds
    • 5.5.1.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Acute wounds
    • 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 5.5.2.2. Surgical & traumatic wounds
    • 5.5.2.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.3. Burns
    • 5.5.2.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Wound dressing Market: End-use Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Hospitals
  • 6.1.2. Outpatient facilities
  • 6.1.3. Home healthcare
  • 6.1.4. Research & manufacturing
• 6.2. End-use Market Share, 2023 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Wound Dressing Market by End-use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Hospitals
    • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
  • 6.5.2. Outpatient facilities
    • 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Home healthcare
    • 6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.4. Research & manufacturing
    • 6.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Wound dressing Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 7.5.3. Canada
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada market estimates and forecasts, 2018 - 2030
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement scenario
    • 7.6.1.5. UK market estimates and forecasts, 2018 - 2030
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. France market estimates and forecasts, 2018 - 2030
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 7.6.6. Denmark
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 7.6.8. Norway
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Norway market estimates and forecasts, 2018 - 2030
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 7.7.2. India
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. India market estimates and forecasts, 2018 - 2030
  • 7.7.3. China
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. China market estimates and forecasts, 2018 - 2030
  • 7.7.4. South Korea
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 7.7.5. Australia
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 7.8.2. Mexico
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Mexico market estimates and forecasts, 2018 - 2030
  • 7.8.3. Argentina
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina market estimates and forecasts, 2018 - 2030
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement scenario
    • 7.9.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis
  • 8.3.4. Smith+Nephew
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Molnlycke Health Care AB
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Convatec Group PLC
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Ethicon (Johnson & Johnson)
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. URGO
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Coloplast Corp.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. 3M
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Integra LifeSciences
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. PAUL HARTMANN AG
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Dr. Ausbuttel & Co. GmbH
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Medline Industries, Inc.
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. Brightwake Ltd.
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives